This content is only available within our institutional offering.

11 Aug 2022
Hikma Pharmaceuticals (Buy) - Updating numbers post 1H22 guidance downgrade

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (Buy) - Updating numbers post 1H22 guidance downgrade
Hikma Pharmaceuticals Plc (HIK:LON) | 1,610 -402.4 (-1.5%) | Mkt Cap: 3,571m
- Published:
11 Aug 2022 -
Author:
Miles Dixon -
Pages:
16 -